Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Hedonistic homeostatic dysregulation is a neuropsychological behavioural disorder associated with substance misuse and addiction. The disorder has been recognised as a consequence of dopamine replacement therapy (DRT) in 15 patients with Parkinson's disease. The syndrome typically develops in male patients with early onset Parkinson's disease, and can occur with orally and subcutaneously administered DRT. These patients take increasing quantities of their DRT, despite increasingly severe drug induced dyskinesias, and may develop a cyclical mood disorder with hypomania or manic psychosis. There is impairment of social and occupational functioning. Tolerance develops to mood elevating effects of DRT and a negative affective withdrawal state occurs if the drugs are withdrawn or doses decreased. The clinical features and guidelines for managing this syndrome are discussed. A set of diagnostic criteria for further investigating this condition is proposed.

[1]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[2]  A. Hughes,et al.  Apomorphine‐induced penile erections in Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[3]  A J Lees,et al.  Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson’s disease , 1998, Journal of neurology, neurosurgery, and psychiatry.

[4]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[5]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[6]  O. Spigset,et al.  Levodopa Dependence and Abuse in Parkinson's Disease , 1997, Pharmacotherapy.

[7]  P. Courty,et al.  Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease. , 1997, Clinical neuropharmacology.

[8]  L. Bauer.  Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients. , 1996, Alcoholism, clinical and experimental research.

[9]  M. Kuhar,et al.  Neurochemical changes in cocaine withdrawal. , 1996, Trends in pharmacological sciences.

[10]  N H Holford,et al.  The response to levodopa in parkinson's disease: Imposing pharmacological law and order , 1996, Annals of neurology.

[11]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[12]  B. Koppel,et al.  Cocaine‐induced choreoathetoid movements ('crack dancing') , 1994, Neurology.

[13]  L. Golbe,et al.  Dopamine‐related personality traits in Parkinson's disease , 1993, Neurology.

[14]  J. Jankovic,et al.  Cocaine‐related movement disorders , 1993, Movement disorders : official journal of the Movement Disorder Society.

[15]  R. Ross,et al.  Bromocriptine abuse , 1992, Biological Psychiatry.

[16]  D. Huppert,et al.  L-dopa abuse in a patient with former alcoholism. , 1992, British journal of addiction.

[17]  Dragan M. Svrakic,et al.  The Tridimensional Personality Questionnaire: U.S. Normative Data , 1991, Psychological reports.

[18]  O. Olowe,et al.  Cocaine and chorea. , 1991, The American journal of emergency medicine.

[19]  B. Angrist,et al.  A pilot trial of levodopa/carbidopa in early cocaine abstinence. , 1990, Journal of clinical psychopharmacology.

[20]  N. Volkow,et al.  Effects of chronic cocaine abuse on postsynaptic dopamine receptors. , 1990, The American journal of psychiatry.

[21]  C. Goetz,et al.  Hypersexuality with antiparkinsonian therapy. , 1989, Clinical neuropharmacology.

[22]  Wade K. Smith,et al.  Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.

[23]  J. Strang,et al.  Cocaine and crack. , 1989, BMJ.

[24]  M W Fischman,et al.  The pharmacology of cocaine related to its abuse. , 1989, Pharmacological reviews.

[25]  N. S. Harvey,et al.  Serial Cognitive Profiles in Levodopa-induced Hypersexuality , 1988, British Journal of Psychiatry.

[26]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[27]  A. Remouchamps,et al.  Levodopa addiction , 1988, Acta psychiatrica Scandinavica.

[28]  J. Raese,et al.  Chronic cocaine administration depletes tyrosine hydroxylase immunoreactivity in the rat brain nigral striatal system: Quantitative light microscopic studies , 1986, Experimental Neurology.

[29]  P A Nausieda,et al.  Sinemet "abusers". , 1985, Clinical neuropharmacology.

[30]  S. Priebe.  Levodopa Dependence: A Case Report , 1984, Pharmacopsychiatry.

[31]  R. Schiffter,et al.  Hypersexuality - a Complication of Dopaminergic Therapy in Parkinson's Disease , 1983, Pharmacopsychiatria.

[32]  E. Schiørring.  Psychopathology Induced by “Speed Drugs” , 1981, Pharmacology Biochemistry and Behavior.

[33]  G. Rylander.  Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. , 1972, Psychiatria, neurologia, neurochirurgia.

[34]  D. Murphy,et al.  Levodopa: Alterations in behavior , 1971, Clinical pharmacology and therapeutics.